Silo Pharma, Inc.
SILO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $18 | $18 | $18 | $18 |
| % Growth | 0% | -0% | 0% | – |
| Cost of Goods Sold | $251 | $1 | $1 | $400 |
| Gross Profit | -$233 | $17 | $17 | -$382 |
| % Margin | -1,291.2% | 91.9% | 91.9% | -2,118.3% |
| R&D Expenses | $544 | $717 | $594 | $1,076 |
| G&A Expenses | $0 | $548 | $517 | $0 |
| SG&A Expenses | $375 | $548 | $517 | $420 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $919 | $1,265 | $1,111 | $1,495 |
| Operating Income | -$1,151 | -$1,249 | -$1,094 | -$1,877 |
| % Margin | -6,388.2% | -6,926.8% | -6,069.7% | -10,414.2% |
| Other Income/Exp. Net | $41 | $44 | $63 | $147 |
| Pre-Tax Income | -$1,110 | -$1,204 | -$1,031 | -$1,731 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,110 | -$1,204 | -$1,031 | -$1,731 |
| % Margin | -6,160.5% | -6,681.2% | -5,721.9% | -9,600.7% |
| EPS | -0.12 | -0.19 | -0.23 | -0.39 |
| % Growth | 36.8% | 17.4% | 41% | – |
| EPS Diluted | -0.12 | -0.19 | -0.23 | -0.39 |
| Weighted Avg Shares Out | 9,331 | 6,280 | 4,484 | 4,484 |
| Weighted Avg Shares Out Dil | 9,331 | 6,280 | 4,484 | 4,484 |
| Supplemental Information | – | – | – | – |
| Interest Income | $45 | $45 | $62 | $83 |
| Interest Expense | $1 | $2 | $2 | $0 |
| Depreciation & Amortization | $3 | $2 | $3 | $3 |
| EBITDA | -$1,107 | -$1,200 | -$1,026 | -$1,791 |
| % Margin | -6,139.3% | -6,658.4% | -5,693.3% | -9,936.5% |